BE435692A - - Google Patents

Info

Publication number

BE435692A

BE435692A BE435692DA BE435692A BE 435692 A BE435692 A BE 435692A BE 435692D A BE435692D A BE 435692DA BE 435692 A BE435692 A BE 435692A

Authority

BE

Belgium

Prior art keywords

operator

line

operator position

devices

repeater

Prior art date

Links

• Espacenet
• Global Dossier
• Discuss

• 238000004891 communication Methods 0.000 claims description 141
• 230000000903 blocking effect Effects 0.000 claims description 94
• 238000012544 monitoring process Methods 0.000 claims description 82
• 230000011664 signaling Effects 0.000 claims description 64
• 210000000056 organ Anatomy 0.000 claims description 39
• 238000012986 modification Methods 0.000 claims 2
• 230000004048 modification Effects 0.000 claims 2
• 239000004020 conductor Substances 0.000 description 430
• 238000004804 winding Methods 0.000 description 230
• 230000005284 excitation Effects 0.000 description 67
• 230000000875 corresponding effect Effects 0.000 description 49
• 241000446313 Lamella Species 0.000 description 26
• 239000003990 capacitor Substances 0.000 description 24
• 230000004044 response Effects 0.000 description 17
• 230000007246 mechanism Effects 0.000 description 15
• 230000000694 effects Effects 0.000 description 10
• 230000006870 function Effects 0.000 description 10
• 238000012360 testing method Methods 0.000 description 10
• 230000001976 improved effect Effects 0.000 description 7
• 102000005962 receptors Human genes 0.000 description 5
• 108020003175 receptors Proteins 0.000 description 5
• 230000003213 activating effect Effects 0.000 description 4
• 230000001276 controlling effect Effects 0.000 description 3
• QPLDLSVMHZLSFG-UHFFFAOYSA-N Copper oxide Chemical compound [Cu]=O QPLDLSVMHZLSFG-UHFFFAOYSA-N 0.000 description 2
• 239000005751 Copper oxide Substances 0.000 description 2
• 230000008033 biological extinction Effects 0.000 description 2
• 230000005540 biological transmission Effects 0.000 description 2
• 229910000431 copper oxide Inorganic materials 0.000 description 2
• 239000012729 immediate-release (IR) formulation Substances 0.000 description 2
• 238000004519 manufacturing process Methods 0.000 description 2
• 230000000284 resting effect Effects 0.000 description 2
• 230000004913 activation Effects 0.000 description 1
• 230000008901 benefit Effects 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 238000006243 chemical reaction Methods 0.000 description 1
• 238000010276 construction Methods 0.000 description 1
• 210000005069 ears Anatomy 0.000 description 1
• 238000005286 illumination Methods 0.000 description 1
• YWTYJOPNNQFBPC-UHFFFAOYSA-N imidacloprid Chemical group [O-][N+](=O)\N=C1/NCCN1CC1=CC=C(Cl)N=C1 YWTYJOPNNQFBPC-UHFFFAOYSA-N 0.000 description 1
• 230000006872 improvement Effects 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 230000001939 inductive effect Effects 0.000 description 1
• 230000003993 interaction Effects 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 238000000034 method Methods 0.000 description 1
• 230000035772 mutation Effects 0.000 description 1
• 230000008569 process Effects 0.000 description 1
• 230000009467 reduction Effects 0.000 description 1
• IOVGROKTTNBUGK-SJCJKPOMSA-N ritodrine Chemical compound N([C@@H](C)[C@H](O)C=1C=CC(O)=CC=1)CCC1=CC=C(O)C=C1 IOVGROKTTNBUGK-SJCJKPOMSA-N 0.000 description 1
• 230000035939 shock Effects 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 230000001960 triggered effect Effects 0.000 description 1